Drug Pipeline

CS0159 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05896137 CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis) Primary Sclerosing Cholangitis Active, Not Recruiting
Phase 1
NCT06485245 Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and… MASH Active, Not Recruiting
Not specified
NCT07570810 Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients… Type 2 Diabetes Not Yet Recruiting
Sponsors Running CS0159 Trials
Cascade Pharmaceuticals, Inc (2) Shanghai Jiao Tong University School of Medicine (1)
Disease Areas
NASH / MASH (1) Type 2 Diabetes (1) Diabetes (1) Obesity (1)
Get alerts when CS0159 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free